Read time: 1 minute

Sara Gideon Raises More Than Twice The Money That Susan Collins Did In Second Quarter

Gideon expanded her fundraising lead, while the Collins spent more than she raised.
Sara Gideon Raises More Than Twice The Money That Susan Collins Did In Second Quarter

The 2020 Senate Race in Maine will be the state's most expensive ever, but it will be a small price to pay to rid the senate of Susan Collins.

Source: Bangor Daily News

House Speaker Sara Gideon, the frontrunner in an upcoming Democratic primary to challenge U.S. Sen. Susan Collins, raised $8.1 million during the pre-primary period, extending her fundraising lead over the incumbent Republican.

Updated fundraising reports were due to the federal government on Thursday covering the period from April 1 through June 24. Gideon’s fundraising surge put her over $23 million in total money raised. She spent $7.2 million in the period, leaving her with $5.5 million in cash on hand. It is the first time she has been left with more cash than Collins after a fundraising period.

Collins raised $3 million while spending $3.6 million, according to federal filings. That brings her total fundraising this cycle to $16.2 million. Her campaign had $5 million in cash on hand at the end of the period.

Have you subscribed yet?

Banish those ads for good with a subscription to the site. For $1 for the first month and $4.99 after that, we'll pull all the ads off (except those from 3rd party apps) so you can enjoy the site without all the annoying popups and autoplay ads.

If you've already subscribed, consider a one-time or donation of whatever amount you can spare. It will be greatly appreciated and help us continue our mission of exposing the real FAKE NEWS!

More C&L Coverage


We welcome relevant, respectful comments. Any comments that are sexist or in any other way deemed hateful by our staff will be deleted and constitute grounds for a ban from posting on the site. Please refer to our Terms of Service (revised 3/17/2016) for information on our posting policy.